A Clinical Review on HMG-CoA Reductase Inhibitors (Statins)-induced Hyperglycemia and New-onset Diabetes Mellitus (NODM)
1. 系统已在2026-08-18 15:47:30对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
NMP Maideen, ARH Jumale, AK Albasti…
Cardiovascular & …, 2026
benthamdirect.com
Introduction Due to their potent lipid-lowering capabilities, 3-hydroxy-3-methylglutyryl-coenzyme A (HMG-CoA) reductase inhibitors, commonly referred to as statins, are widely utilized for the primary and secondary prevention of cardiovascular disease. However, there is growing evidence that statin use may be associated with an increased risk of hyperglycemia and new-onset diabetes mellitus (NODM). This narrative review aims to summarize current understanding of statin-induced NODM by examining clinical data …
